The sensitivity of STAT6 for the diagnosis of solitary fibrous tumors has been reported to range from 86 to 98% in large series at both CNS and soft-tissue sites [7, 9, 13, 17]. This evidence concerns the gene STAT6 and solitary fibrous tumor.